Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

被引:398
作者
Nakano, Hiroshi [1 ]
Oussoultzoglou, Elie [1 ]
Rosso, Edoardo [1 ]
Casnedi, Selenia [3 ]
Chenard-Neu, Marie-Pierre [3 ]
Dufour, Patrick [2 ]
Bachellier, Philippe [1 ]
Jaeck, Daniel [1 ]
机构
[1] Univ Strasbourg, Hop Univ Strasbourg, Hop Hautepierre, Ctr Chirurg Viscerale & Transplant, F-67200 Strasbourg, France
[2] Ctr Reg Lutte Canc Strasbourg, Ctr Paul Strauss, Strasbourg, France
[3] Univ Strasbourg, Hop Univ Strasbourg, Hop Hautepierre, Serv Anat Pathol, F-67200 Strasbourg, France
关键词
D O I
10.1097/SLA.0b013e31815774de
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To investigate whether sinusoidal injury (SI) was associated with a worse outcome after hepatectomy in patients with colorectal liver metastases (CRLM). Background: Correlation between SI and oxaliplatin-based chemotherapy (OBC) was recently shown in patients with CRLM. However, it has yet to be fully clarified whether SI affects liver functional reserve and outcome after hepatectomy. Patients and Methods: Between 2003 and 2005, 90 patients with CRLM who underwent an elective hepatectomy after preoperative chemotherapies were included. Diagnosis of SI was established pathologically in the nontumoral liver parenchyma of the resected specimens, and perioperative data were assessed in these patients. Results: OBC was significantly associated with a higher incidence of SI. Preoperative indocyanine green retention rate at 15 minutes (ICG-R15) and postoperative value of total-bilirubin were significantly higher. and hospital stay was significantly longer in patients presenting with SI. Multivariate analysis showed that female gender, administration of 6 cycles or more of OBC, abnormal value of preoperative aspartate aminotransferase > 36 IU/L, or abnormal value of preoperative ICG-R15 (> 10%) were preoperative factors significantly associated with SI. Among patients undergoing a major hepatectomy, SI was significantly associated with higher morbidity and longer hospital stay. Conclusion: The present study suggests that SI resulted in a poorer liver functional reserve and in a higher complication rate after major hepatectomy. Therefore, female patients who received 6 cycles or more of OBC. or presenting with abnormal preoperative aspartate aminotransferase and ICG-R15 values should be carefully selected before deciding to undertake a major hepatectomy.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 41 条
  • [1] Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  • [2] Adam R, 2005, J CLIN ONCOL, V23, p253S
  • [3] Liver resection for colorectal metastases - The third hepatectomy
    Adam, R
    Pascal, G
    Azoulay, D
    Tanaka, K
    Castaing, D
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2003, 238 (06) : 871 - 883
  • [4] Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study
    Alberts, SR
    Horvath, WL
    Stcrnfeld, WC
    Goldberg, RM
    Mahoney, MR
    Dakhil, SR
    Levitt, R
    Rowland, K
    Nair, S
    Sargent, DJ
    Donohue, JH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9243 - 9249
  • [5] Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization
    Azoulay, D
    Castaing, D
    Smail, A
    Adam, R
    Cailliez, V
    Laurent, A
    Lemoine, A
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2000, 231 (04) : 480 - 486
  • [6] The "50-50 criteria" on postoperative day 5 - An accurate predictor of liver failure and death after hepatectomy
    Balzan, S
    Belghiti, J
    Farges, O
    Ogata, S
    Sauvanet, A
    Delefosse, D
    Durand, F
    [J]. ANNALS OF SURGERY, 2005, 242 (06) : 824 - 829
  • [7] Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection
    Behrns K.E.
    Tsiotos G.G.
    DeSouza N.F.
    Krishna M.K.
    Ludwig J.
    Nagorney D.M.
    [J]. Journal of Gastrointestinal Surgery, 1998, 2 (3) : 292 - 298
  • [8] Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note
    Bilchik, AJ
    Poston, G
    Curley, SA
    Strasberg, S
    Saltz, L
    Adam, R
    Nordlinger, B
    Rougier, P
    Rosen, LS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9073 - 9078
  • [9] Bismuth H, 1998, SEMIN ONCOL, V25, P40
  • [10] Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    Bismuth, H
    Adam, R
    Levi, F
    Farabos, C
    Waechter, F
    Castaing, D
    Majno, P
    Engerran, L
    [J]. ANNALS OF SURGERY, 1996, 224 (04) : 509 - 520